tiprankstipranks
Rubius Therapeutics (RUBY)
OTHER OTC:RUBY
US Market

Rubius Therapeutics (RUBY) Technical Analysis

220 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Rubius Therapeutics’s (RUBY) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Rubius Therapeutics is a Sell.
Rubius Therapeutics’s (RUBY) 20-Day exponential moving average is 0.04, while Rubius Therapeutics’s (RUBY) share price is <$0.1, making it a Buy.
Rubius Therapeutics’s (RUBY) 50-Day exponential moving average is 0.03, while Rubius Therapeutics’s (RUBY) share price is <$0.1, making it a Buy.

Rubius Therapeutics (RUBY) Pivot Points

Apr 27, 2024, 03:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Fibonacci
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rubius Therapeutics (RUBY) Moving Averages

Apr 27, 2024, 03:02 PM
Period
Simple
Exponential
MA5
0.06Buy
0.06Buy
MA10
0.06Buy
0.05Buy
MA20
0.04Buy
0.04Buy
MA50
0.03Buy
0.03Buy
MA100
0.02Buy
0.03Buy
MA200
0.02Buy
0.05Buy
Rubius Therapeutics’s (RUBY) 10-Day exponential moving average is 0.05, while Rubius Therapeutics’s (RUBY) share price is <$0.1, making it a Buy.
Rubius Therapeutics’s (RUBY) 100-Day exponential moving average is 0.03, while Rubius Therapeutics’s (RUBY) share price is <$0.1, making it a Buy.
Rubius Therapeutics’s (RUBY) stock price is <$0.1 and Rubius Therapeutics’s (RUBY) 50-day simple moving average is 0.03, creating a Buy signal.
Rubius Therapeutics’s (RUBY) stock price is <$0.1 and Rubius Therapeutics’s (RUBY) 100-day simple moving average is 0.02, creating a Buy signal.
Rubius Therapeutics’s (RUBY) stock price is <$0.1 and Rubius Therapeutics’s (RUBY) 200-day simple moving average is 0.02, creating a Buy signal.

Rubius Therapeutics (RUBY) Technical Indicators

Apr 27, 2024, 03:02 PM
Name
Value
Implied Action
RSI (14)
90.31
Sell
STOCH (9,6)
119.62
Sell
STOCHRSI (14)
107.89
Sell
MACD (12,26)
0.01
Sell
ADX (14)
91.44
Sell
Williams %R
7.89
Sell
CCI (14)
75.70
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
100.51
Buy
ROC
200.00
Buy
Rubius Therapeutics’s (RUBY) Relative Strength Index (RSI) is 90.31, creating a Sell signal.
Rubius Therapeutics’s (RUBY) Trend Strength Indicator (ADX) is 91.44, creating a Sell signal.
Rubius Therapeutics’s (RUBY) Commodity Channel Index (CCI) is 75.70, creating a Neutral signal.
Rubius Therapeutics’s (RUBY) Price Rate of Change (ROC) is 200.00, creating a Buy signal.

FAQ

Is RUBY a Buy, Hold, or Sell?
Based on RUBY’s technical indicators, RUBY is a Buy.
    What is RUBY’s RSI (14)?
    RUBY’s RSI (14) is 90.31, which suggests RUBY is a Sell.
      What is RUBY’s MACD?
      RUBY’s MACD is 0.01, which suggests RUBY is a Sell.
        What is RUBY’s 5-day moving average?
        RUBY’s 5-day moving average is 0.06, which suggests RUBY is a Buy.
          What is RUBY’s 20-day moving average?
          RUBY 20-day moving average is 0.04, which suggests RUBY is a Buy.
            What is RUBY’s 50-day moving average?
            RUBY’s 50-day moving average is 0.03, which suggests RUBY is a Buy.
              What is RUBY’s 200-day moving average?
              RUBY’s 200-day moving average is 0.02, which suggests RUBY is a Buy.
                What is RUBY’s Williams % R (14)?
                RUBY’s Williams % R (14) is 7.89, which suggests RUBY is a Sell.
                  What is RUBY’s CCI (14)?
                  RUBY’s CCI (14) is 75.70, which suggests RUBY is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis